These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29371980)

  • 1. Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy.
    Paret C; Russo A; Otto H; Mayer A; Zahnreich S; Wagner W; Samuel D; Scharnhorst D; Solomon DA; Dhall G; Wong K; Bender H; Alt F; Wingerter A; Neu MA; Beck O; Prawitt D; Eder S; Henninger N; El Malki K; Lehmann N; Backes N; Roth L; Seidmann L; Sommer C; Brockmann MA; Staatz G; Schmidberger H; Faber J
    Oncotarget; 2017 Dec; 8(69):114210-114225. PubMed ID: 29371980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy.
    Paret C; Theruvath J; Russo A; Kron B; El Malki K; Lehmann N; Wingerter A; Neu MA; Gerhold-Ay A; Wagner W; Sommer C; Pietsch T; Seidmann L; Faber J
    Oncotarget; 2016 Dec; 7(50):83378-83391. PubMed ID: 27825128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF1R Is a Potential New Therapeutic Target for HGNET-BCOR Brain Tumor Patients.
    Vewinger N; Huprich S; Seidmann L; Russo A; Alt F; Bender H; Sommer C; Samuel D; Lehmann N; Backes N; Roth L; Harter PN; Filipski K; Faber J; Paret C
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HGNET-BCOR Tumors of the Cerebellum: Clinicopathologic and Molecular Characterization of 3 Cases.
    Appay R; Macagno N; Padovani L; Korshunov A; Kool M; André N; Scavarda D; Pietsch T; Figarella-Branger D
    Am J Surg Pathol; 2017 Sep; 41(9):1254-1260. PubMed ID: 28704208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNS high-grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue.
    Yoshida Y; Nobusawa S; Nakata S; Nakada M; Arakawa Y; Mineharu Y; Sugita Y; Yoshioka T; Araki A; Sato Y; Takeshima H; Okada M; Nishi A; Yamazaki T; Kohashi K; Oda Y; Hirato J; Yokoo H
    Brain Pathol; 2018 Sep; 28(5):710-720. PubMed ID: 29226988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single supratentorial high-grade neuroepithelial tumor with two distinct BCOR mutations, exceptionally long complete remission and survival.
    Bremer J; Kottke R; Johann PD; von Hoff K; Brazzola P; Grotzer MA; Kool M; Rushing E; Gerber NU
    Pediatr Blood Cancer; 2020 Jul; 67(7):e28384. PubMed ID: 32383815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis.
    Ferris SP; Velazquez Vega J; Aboian M; Lee JC; Van Ziffle J; Onodera C; Grenert JP; Saunders T; Chen YY; Banerjee A; Kline CN; Gupta N; Raffel C; Samuel D; Ruiz-Diaz I; Magaki S; Wilson D; Neltner J; Al-Hajri Z; Phillips JJ; Pekmezci M; Bollen AW; Tihan T; Schniederjan M; Cha S; Perry A; Solomon DA
    Brain Pathol; 2020 Jan; 30(1):46-62. PubMed ID: 31104347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system high-grade neuroepithelial tumor with BCOR alteration (CNS HGNET-BCOR)-case-based reviews.
    De Lima L; Sürme MB; Gessi M; Mastronuzzi A; Miele E; Tamburrini G; Massimi L
    Childs Nerv Syst; 2020 Aug; 36(8):1589-1599. PubMed ID: 32542405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular identification of CNS NB-FOXR2, CNS EFT-CIC, CNS HGNET-MN1 and CNS HGNET-BCOR pediatric brain tumors using tumor-specific signature genes.
    Łastowska M; Trubicka J; Sobocińska A; Wojtas B; Niemira M; Szałkowska A; Krętowski A; Karkucińska-Więckowska A; Kaleta M; Ejmont M; Perek-Polnik M; Dembowska-Bagińska B; Grajkowska W; Matyja E
    Acta Neuropathol Commun; 2020 Jul; 8(1):105. PubMed ID: 32650833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Wound Site Seeding in a Patient with Central Nervous System High-Grade Neuroepithelial Tumor with BCOR Alteration.
    Kirkman MA; Pickles JC; Fairchild AR; Avery A; Pietsch T; Jacques TS; Aquilina K
    World Neurosurg; 2018 Aug; 116():279-284. PubMed ID: 29859355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma.
    Ally MS; Ransohoff K; Sarin K; Atwood SX; Rezaee M; Bailey-Healy I; Kim J; Beachy PA; Chang AL; Oro A; Tang JY; Colevas AD
    JAMA Dermatol; 2016 Apr; 152(4):452-6. PubMed ID: 26765315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, pathological, and molecular features of central nervous system tumors with BCOR internal tandem duplication.
    Wang W; Zhang A; Li Y; Wang D; Chen L; Li Q; Chen J; Li H; Sun S; Pan M; Zhou W; Wu H
    Pathol Res Pract; 2024 Jul; 259():155367. PubMed ID: 38797130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features.
    Torre M; Meredith DM; Dubuc A; Solomon DA; Perry A; Vasudevaraja V; Serrano J; Snuderl M; Ligon KL; Alexandrescu S
    J Neuropathol Exp Neurol; 2019 Apr; 78(4):305-314. PubMed ID: 30816933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Cerebellar High-Grade Neuroepithelial Tumour with BCOR Alteration in a five-year-old Child: A case report.
    Al-Battashi A; Al Hajri Z; Perry A; Al-Kindi H; Al-Ghaithi I
    Sultan Qaboos Univ Med J; 2019 May; 19(2):e153-e156. PubMed ID: 31538015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific and Sensitive Diagnosis of
    Barets D; Appay R; Heinisch M; Battistella M; Bouvier C; Chotard G; Le Loarer F; Macagno N; Perbet R; Pissaloux D; Rousseau A; Tauziède-Espariat A; Varlet P; Vasiljevic A; Colin C; Fina F; Figarella-Branger D
    Front Oncol; 2021; 11():645512. PubMed ID: 33718245
    [No Abstract]   [Full Text] [Related]  

  • 16. CNS tumor with BCOR internal tandem duplication: Clinicopathologic, molecular characteristics and prognosis factors.
    Wang R; Guan W; Qiao M; Zhang Y; Zhang M; Wang K; Wang Y; Wang L
    Pathol Res Pract; 2022 Aug; 236():153995. PubMed ID: 35809497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCOR Positive Central Nervous System Neuroepithelial Tumor Masquerading as a Meningioma.
    Ahuja S; Khan AA; Zaheer S
    Indian J Surg Oncol; 2024 Jun; 15(2):359-363. PubMed ID: 38741634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
    Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
    Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of arsenic trioxide resistant clones derived from Jurkat leukemia T cell line: focus on PI3K/Akt signaling pathway.
    Roszak J; Smok-Pieniążek A; Nocuń M; Stępnik M
    Chem Biol Interact; 2013 Oct; 205(3):198-211. PubMed ID: 23911876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.